The Role of Social Media in the Communication of Leaders

This thesis explores the impact of social media on leadership. For this purpose, it presents a new model for the communication of leaders. This builds on the empirical finding; that leaders must optimize two elements in order to communicate effectively; communication channel and communication style. It then seeks to explore the impact of social media on this model. On a general level, this impact is categorized into five subparts; openness, transparency, personification, power, and control. On a more spesific level, the thesis also proposes specific impacts of social media on the communication channels and styles of leaders

Passiv medvirkning til vold mot barn. Hvor langt strekker straffansvaret seg for omsorgspersoner?

MasteroppgaveJUS399MAJURMAJUR-

Exploring staff diabetes medication knowledge and practices in regional residential care: triangulation study

Aims and objectives: This study is drawn from a larger project that aimed to identify the staffing and organisational factors influencing the quality of diabetes care for older people living in residential care in regional Victoria, Australia. The focus of the current study is on medication management for residents with diabetes. Background: With a continuous rise in diabetes in the population, there is an associated increase in the prevalence of diabetes in aged care residential settings. However, there is little specific guidance on how to manage diabetes in older people living in institutional settings who experience multiple concurrent chronic conditions. Design: A triangulation strategy consisting of three phases. Methods: A one-shot cross-sectional survey (n = 68) focus group interviews and a case file audit (n = 20). Data were collected between May 2009-January 2010. Findings: Staff knowledge of diabetes and its contemporary medication management was found to be suboptimal. Challenges to managing residents with diabetes included limited time, resident characteristics and communication systems. Additionally, the variability in medical support available to residents and a high level of polypharmacy added to the complexity of medication management of resident. Conclusions: The current study suggests administering medicine to residents in aged care settings is difficult and has potentially serious medical, professional and economic consequences. Limitations to staff knowledge of contemporary diabetes care and medications potentially place residents with diabetes at risk of receiving less than optimal diabetes care. Relevance to clinical practice: Providing evidence-based guidelines about diabetes care in residential care settings is essential to achieve acceptable outcomes and increase the quality of life for residents in public aged care. Continuing education programs in diabetes care specifically related to medication must be provided to all health professionals and encompass scope of practice. © 2013 John Wiley & Sons Ltd

Punktumets pragmatiske funksjon i tekstmeldinger

I denne masteroppgaven har jeg undersøkt punktumets pragmatiske funksjon når det opptrer på slutten av korte tekstmeldingsresponser. Tidligere utenlandske studier har funnet at punktum kan bidra til å formidle et meningsinnhold blant unge språkbrukere, og jeg har undersøkt hvorvidt dette også er tilfellet blant norske språkbrukere. Jeg har gjennomført en kvantitativ spørreundersøkelse, hvor resultatene er analysert og diskutert i lys av relevansteoretiske perspektiver. Resultatene viser at det er en forskjell mellom hvordan eldre og yngre aldersgrupper tolker tekstmeldinger som avsluttes med et punktum, hvor punktumet ikke ser ut til å ha en pragmatisk funksjon for den eldste aldergruppen. Den yngste aldersgruppen (15-25 år) tolker tekstmeldingene som avsluttes med og uten punktum ulikt, der tekstmeldinger som avsluttes med punktum oppleves som mer negative, formelle, og mindre vennlige enn tekstmeldingene uten punktum. Funnene i denne masteroppgaven tyder på at punktum har en pragmatisk funksjon hos den yngste aldersgruppen, men at denne funksjonen varierer mellom ulike språkbrukere. Jeg finner indikasjoner på at det kan eksistere to ulike punktumtegn: i) det allerede eksisterende, tradisjonelle punktumet, hvor den yngste aldersgruppen utleder implikaturer basert på kontekstuelle antakelser for å tolke avsenders intenderte mening med ytringen, og ii) at det kan ha oppstått, eller er i ferd med å oppstå, et nytt punktum der enkelte språkbrukere har leksikalisert uttrykket slik at det bærer en fast, prosedural semantikk. Denne semantikken har jeg foreslått å være at avsender er mindre positivt innstilt til et tilgjengelig saksforhold p. Dersom det har oppstått et nytt punktum, vil dette punktumet være en ekspressiv pragmatisk markør.In this master’s thesis, I have examined the pragmatic function of the period when it appears at the end of short text message responses. Previous international studies have found that the period can contribute to conveying meaning among young language users, and I have investigated whether this is also the case among Norwegian speakers. I conducted a quantitative survey, and the results have been analyzed and discussed in light of relevance-theoretic perspectives. The findings show a difference in how older and younger age groups interpret text messages ending with a period. For the oldest age group, the period does not appear to serve a pragmatic function. The youngest age group (15–25 years) interprets text messages with and without a period differently, with messages ending with a period being perceived as more negative, formal, and less friendly than those without a period. The findings of this thesis suggest that the period holds a pragmatic function for the youngest age group, though this function varies among different language users. I find indications that two distinct period markers may exist: i) the already established, traditional period, where the youngest age group infers implicatures based on contextual assumptions to infer the speaker’s intended meaning, and ii) the emergence, or potential emergence, of a new period, where some speakers have lexicalized the marker so that it carries a fixed, procedural semantics. I propose that this semantics signals that the sender holds a less positive attitude toward an accessible proposition p. If such a new period has indeed emerged, it would function as an expressive pragmatic marker

The Janus face of polypharmacy – overuse versus underuse of medication

As modern guidelines may recommend several drugs for a single medical condition, it follows that many patients, especially if co-morbidity is present, use a number of medications. Also, an aging population implies more morbidity and consequently will have the result that many patients use many drugs – a situation often referred to as polypharmacy. Polypharmacy has been linked to negative health outcomes such as adverse drug reactions, interaction problems, poor patient adherence, and hospitalisations. Such experiences have led to the attitude that efforts should be made to reduce polypharmacy. However, this approach might prevent patients from obtaining optimal treatment. There is no universal definition of polypharmacy and measuring of a reduction in polypharmacy becomes problematic. Because polypharmacy is an imprecise term it should be used with caution in research as well as in patient management. Moreover, studies have shown that undertreatment occurs frequently also among patients using many drugs. This is the Janus face of polypharmacy: too many drugs should be avoided, but the individual patient should receive the appropriate drugs that have the potential to reduce morbidity and improve quality of life. It is the individual drugs themselves, along with patient specific factors, and not a fixed number of drugs, that we should pay attention to.</jats:p

Quality Improvement Project to Evaluate Discharge Prescriptions in Children With Cystic Fibrosis

Introduction: Cystic Fibrosis (CF) requires multiple pharmaceutical treatments, elevating the risk of medication errors (ME), which may compromise patient safety. This study aimed to improve the quality of discharge prescriptions (DPs) using indicators following admissions for IV antibiotics in pediatric CF patients. Methods: This project involved a longitudinal observational retrospective descriptive study followed by a longitudinal quasi-experimental prospective phase between January 2013 and December 2016 in CF patients admitted to a London Children's Hospital. The CF pharmacist reviewed DPs. Six rights of medication administration were defined (6R): dose, drug, frequency, duration of treatment, pharmaceutical form, and route of administration. We classified ME according to 6R, including subtype of error: committed/omitted. We calculated quality indicators by dividing the number of each correct parameter defined by 6R by number of DPs. Retrospective results were used prospectively to describe and implement improvement strategies and safety actions. Results: The retrospective study phase included 42 CF children (100 hospital admissions and 1,343 drugs). The prospective phase included thirty-five children (55 admissions and 822 drugs). The total number of ME identified was 148 (78 committed; 70 omitted) in retrospective phase and 135 (19 committed; 116 omitted) in prospective phase. Quality indicators for drug and dose showed significant improvement after implementing safety strategies. The global quality indicator increased from 22% (retrospective) to 41.82% (prospective), but we did not achieve the previously defined quality standard value (50%). Conclusions: A retrospective review of DP by a CF Pharmacist identified failures in DP quality. Implementing improvement strategies improved prescribing. Integrating pharmacist within multidisciplinary team improves DP reducing errors

Drug-related problems in home-dwelling older adults: a systematic review

Purpose:The complex combination of medicinesassociated with age-related physiological alterationsleads older adults to experience drug-relatedproblems (DRPs). The goal of this study was toreview the frequency and type of DRPs and DRP riskfactors in home-dwelling older adults.Methods:A MEDLINE PubMed and EMBASEscientific databases search was performed. Articlespublished from January 2000 through December2018 reporting DRPs in home-dwelling older adultswere included.Findings:From 668 articles screened, 13 met theinclusion criteria and were included in this study.Overall, the studies included 8935 home-dwellingpatients. The mean number of DRPs per patientobserved was 4.16 (1.37e10). The main causes ofDRPs were“drug selection”(51.41%),“dose selection”(11.62%), and“patient related”(10.70%) problems.The drug classes more frequently associated withDRPs were“cardiovascular system,”“alimentary tractand metabolism,”and“nervous system,”and theyrepresented 32.1%, 29.4%, and 16.5% of all drugselection problems, respectively. Respiratory systemmedicines accounted for 6.65% of all DRPs, of which“patient related”problems accounted for 97.28%.Implications:Despite the heterogeneity ofmethodology of the included studies and theheterogeneity of tools used to identify DRPs, thisanalysis clearly shows the high prevalence of DRPs inhome-dwelling older adults and highlights the needfor interventions to improve medicine use in thispopulation. This work also provides usefulinformation for the development of strategies toimprove medication use in home-dwelling olderadults.publishe

The process of identifying, solving and preventing drug related problems in the LIMM-study

Objective To avoid negative effects of drug treatment and need for additional medical care, drug treatment must be individualised. Our research group has developed a model for clinical pharmacy which improves several aspects of the patient's drug treatment. This study describes the process behind these improvements, i.e. drug related problems identified by pharmacists within a clinical pharmacy service. Setting Three wards at a department of internal medicine. Method Pharmacists performed systematic interventions during the patient's hospital stay, aiming to identify, solve and prevent drug related problems in the elderly. Identified drug related problems were put forward to the health care team and discussed. Information on identified problems, and their outcomes was collected and analysed. A questionnaire was used to evaluate the health care personnel's attitudes towards the process. Main outcome measure The number of drug related problems identified by the clinical pharmacists, the proportion of problems discussed with the physicians, the proportion of problems adjusted by the physicians and whether pharmacists and physicians prioritised any subgroup of drug related problems when choosing which problems to address. Finally, we wanted to evaluate the health care personnel's attitudes towards the model. Results In total, 1,227 problem were identified in 190 patients. The pharmacists discussed 685 (55.8%) of the identified problems with the physicians who accepted 438 (63.9%) of the suggestions. There was no significant difference in which subgroup to put forward and which to adjust. There was a high response rate (84%) to the questionnaire, and the health care personnel estimated the benefits to be very high, both for the patients and for themselves. Conclusion The process for identifying, solving and preventing drug related problems was good and the different types of problems were considered equally important. The addition of a clinical pharmacy service was considered very useful. This suggests that the addition of our clinical pharmacy service to the hospital setting add skills of great importance

Clinical pharmacy activities in chronic kidney disease and end-stage renal disease patients: a systematic literature review

<p>Abstract</p> <p>Background</p> <p>Chronic kidney disease (CKD) and end-stage renal disease (ESRD) represent worldwide health problems with an epidemic extent. Therefore, attention must be given to the optimisation of patient care, as gaps in the care of CKD and ESRD patients are well documented. As part of a multidisciplinary patient care strategy, clinical pharmacy services have led to improvements in patient care. The purpose of this study was to summarise the available evidence regarding the role and impact of clinical pharmacy services for these patient populations.</p> <p>Methods</p> <p>A literature search was conducted using the <it>Medline</it>, <it>Embase </it>and <it>International Pharmaceutical Abstracts </it>databases to identify relevant studies on the impact of clinical pharmacists on CKD and ESRD patients, regarding disease-oriented and patient-oriented outcomes, and clinical pharmacist interventions on drug-related problems.</p> <p>Results</p> <p>Among a total of 21 studies, only four (19%) were controlled trials. The majority of studies were descriptive (67%) and before-after studies (14%). Interventions comprised general clinical pharmacy services with a focus on detecting, resolving and preventing drug-related problems, clinical pharmacy services with a focus on disease management, or clinical pharmacy services with a focus on patient education in order to increase medication knowledge. Anaemia was the most common comorbidity managed by clinical pharmacists, and their involvement led to significant improvement in investigated disease-oriented outcomes, for example, haemoglobin levels. Only four of the studies (including three controlled trials) presented data on patient-oriented outcomes, for example, quality of life and length of hospitalisation. Studies investigating the number and type of clinical pharmacist interventions and physician acceptance rates reported a mean acceptance rate of 79%. The most common reported drug-related problems were incorrect dosing, the need for additional pharmacotherapy, and medical record discrepancies.</p> <p>Conclusions</p> <p>Few high-quality trials addressing the benefit and impact of clinical pharmacy services in CKD and ESRD patients have been published. However, all available studies reported some positive impact resulting from clinical pharmacist involvement, including various investigated outcome measures that could be improved. Additional randomised controlled trials investigating patient-oriented outcomes are needed to further determine the role of clinical pharmacists and the benefits of clinical pharmacy services to CKD and ESRD patients.</p

The effect of an active on-ward participation of hospital pharmacists in Internal Medicine teams on preventable Adverse Drug Events in elderly inpatients: protocol of the WINGS study (Ward-oriented pharmacy in newly admitted geriatric seniors)

<p>Abstract</p> <p>Background</p> <p>The potential of clinical interventions, aiming at reduction of preventable Adverse Drug Events (preventable ADEs) during hospital stay, have been studied extensively. Clinical Pharmacy is a well-established and effective service, usually consisting of full-time on-ward participation of clinical pharmacists in medical teams. Within the current Hospital Pharmacy organisation in the Netherlands, such on-ward service is less feasible and therefore not yet established. However, given the substantial incidence of preventable ADEs in Dutch hospitals found in recent studies, appears warranted. Therefore, "Ward-Oriented Pharmacy", an on-ward service tailored to the Dutch hospital setting, will be developed. This service will consist of multifaceted interventions implemented in the Internal Medicine wards by hospital pharmacists. The effect of this service on preventable ADEs in elderly inpatients will be measured. Elderly patients are at high risk for ADEs due to multi-morbidity, concomitant disabilities and polypharmacy. Most studies on the incidence and preventability of ADEs in elderly patients have been conducted in the outpatient setting or on admission to a hospital, and fewer in the inpatient setting. Moreover, recognition of ADEs by the treating physicians is challenging in elderly patients because their disease presentation is often atypical and complex. Detailed information about the performance of the treating physicians in ADE recognition is scarce.</p> <p>Methods/Design</p> <p>The design is a multi-centre, interrupted time series study. Patients of 65 years or older, consecutively admitted to Internal Medicine wards will be included. After a pre-measurement, a Ward-Oriented Pharmacy service will be introduced and the effect of this service will be assessed during a post-measurement. The primary outcome measures are the ADE prevalence on admission and ADE incidence during hospital stay. These outcomes will be assessed using structured retrospective chart review by an independent expert panel. This assessment will include determination of causality, severity and preventability of ADEs. In addition, the extent to which ADEs are recognised and managed by the treating physicians will be considered.</p> <p>Discussion</p> <p>The primary goal of the WINGS study is to assess whether a significant reduction in preventable ADEs in elderly inpatients can be achieved by a Ward-Oriented Pharmacy service offered. A comprehensive ADE detection method will be used based on expert opinion and retrospective, trigger-tool enhanced, chart review.</p> <p>Trial registration</p> <p>ISRCTN: <a href="http://www.controlled-trials.com/ISRCTN64974377">ISRCTN64974377</a></p